Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE

moksha8 Expands Alliance With Roche to Commercialize $200 Million of Productsin Brazil and Mexico

By Pharmaceutical Processing | May 20, 2009

moksha8,Inc. has expanded its strategic partnership with Rocheto commercialize an additional portfolio of products in Mexico currentlygenerating sales of $140 million USD. moksha8 will commercialize products in three therapeutic areas, CNSdisease, anti-infectives, and inflammation. The product portfolio consists ofwell-known brands including Rivotril(R), Rocephin(R) and Bactrim(R).”moksha8 has produced strong results for Roche in Brazil and we aredelighted to expand our relationship to include Mexico as a key country inLatin America,” said Ernest Egli, President of Roche Latin America. “moksha8brings strong commercial capabilities and innovative marketing to our CNS,anti-infectives and inflammation franchises. We look forward to continuingthis valuable relationship.” “moksha8 has established a broad footprint in Latin America with leadingproducts that are cornerstones of medical care,” said Simba Gill, CEO ofmoksha8. “We look forward to continuing our strong relationship with Rocheand driving value from this important portfolio of products. We are nowfirmly positioned as the leading partner of choice for pharmaceutical andbiotechnology companies looking to generate value across Latin America.”In just over a year, moksha8 has grown its commercial organization to over200 employees in Brazil and Mexico and a portfolio of products with sales of$200 million USD. moksha8 is uniquely positioned as the leading specialtypharmaceutical company in Latin America with a strong presence in CNS,anti-infectives and inflammation.

Related Articles Read More >

These are the logos of Otsuka Medical and ICU Medical.
ICU Medical, Otsuka Pharmaceutical Factory launch joint IV supply chain venture
Amgen
Amgen to spend $900M to expand U.S. biopharma manufacturing
Roche
Roche to invest $50B in U.S. over next five years
Thermo Fisher Scientific
Thermo Fisher to invest $2B on U.S. manufacturing
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Advertise
  • SUBSCRIBE